K050113

Substantially Equivalent

TINA-QUANT IGG GEN.2

Applicant: Roche Diagnostics Corp.
Product code: DEW
Advisory panel: Immunology
Date received: 2005-01-18
Decision date: 2005-02-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.